111 Capital’s Eli Lilly LLY Stock Holding History

111 Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.51M	Buy	3,764 +978	+35%	+$999K	0.78%	23
2026 Q1	$2.56M	Buy	2,786 +756	+37%	+$766K	0.63%	27
2025 Q4	$2.18M	Buy	2,030 +1,376	+210%	+$1.32M	0.48%	32
2025 Q3	$499K	Sell	654 -864	-57%	-$643K	0.09%	217
2025 Q2	$1.18M	Sell	1,518 -1,403	-48%	-$1.09M	0.2%	110
2025 Q1	$2.41M	Buy	+2,921	New	+$2.43M	0.47%	38

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

111 Capital's LLY Position: Q2 2026 in Review

111 Capital increased its Eli Lilly (LLY) stake by 35% in Q2 2026, buying an estimated $999K and bringing the position to 3,764 shares worth $4.51M. The position accounts for 0.78% of the portfolio, ranked #23.

111 Capital first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,637 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

111 Capital held 3,764 shares of Eli Lilly worth $4.51M as of Q2 2026.
111 Capital bought 978 Eli Lilly shares in Q2 2026, an estimated $999K.
Eli Lilly made up 0.78% of 111 Capital's portfolio in Q2 2026, its #23 holding.
111 Capital first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
4,637 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.